Simpson Thacher is representing Warburg Pincus in connection with the first close of an expected $200 million Series B financing for Helix. Warburg Pincus is a significant investor in Helix and participated in the financing alongside new investor DFJ Growth and certain other existing investors. Simpson Thacher previously represented Warburg Pincus in connection with the formation of Helix and its initial $100 million financing.
Helix will use this financing to continue to accelerate consumer adoption of genomics via the expansion of its trusted marketplace. The marketplace features a growing list of world-class partners, all committed to developing innovative health-focused products powered by Next Generation Sequencing.
Helix, headquartered in San Francisco, is a personal genomics company that handles sample collection, DNA sequencing and secure data storage, and provides a marketplace of services through various partners, so that their partners can integrate DNA insights into products across a range of categories including ancestry, entertainment, family, fitness, health and nutrition.
The Simpson Thacher team includes Robert Langdon and Mark Myott (Corporate); David Rubinsky and Jeannine McSweeney (ECEB); and Jacqueline Clinton (Tax).